Advertisement
TwistDx
TwistDx

The Scientist

» biobusiness

Most Recent

image: Banking on iPSCs

Banking on iPSCs

By | June 30, 2014

A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.

0 Comments

image: Agencies Partner to Help Commercialize Biomedical Discoveries

Agencies Partner to Help Commercialize Biomedical Discoveries

By | June 19, 2014

Collaborative effort from the US National Science Foundation and National Institutes of Health offers business training for federally funded researchers.

0 Comments

image: Guidelines for Gene Patent Ruling

Guidelines for Gene Patent Ruling

By | March 7, 2014

The USPTO offers guidance to its patent examiners on how to interpret the Supreme Court’s rulings in the recent Myriad and Prometheus cases.

0 Comments

image: Venter's New Venture

Venter's New Venture

By | March 5, 2014

The genomics pioneer is starting a new company that aims to tackle the mysteries of human aging.

0 Comments

image: Incubator Boom

Incubator Boom

By | March 1, 2014

From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?  

1 Comment

image: Geron’s Stem Cell Program Sold

Geron’s Stem Cell Program Sold

By | October 2, 2013

The company, which launched the first ever clinical trial for a human embryonic stem cell therapy before shuttering its stem cell arm, has finally struck a deal with BioTime.

0 Comments

image: Biotech IPOs Surge

Biotech IPOs Surge

By | August 23, 2013

The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.

0 Comments

image: Sanofi Thief Reprimanded

Sanofi Thief Reprimanded

By | May 8, 2012

A former Sanofi research scientist is sentenced to 18 months in prison for stealing trade secrets.

0 Comments

image: Treating Fat with Fat

Treating Fat with Fat

By | May 1, 2012

Is brown fat ready for therapeutic prime time?

22 Comments

image: Braving the IPO Drought

Braving the IPO Drought

By | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

0 Comments

Advertisement
Thermo Scientific
Thermo Scientific

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
The Scientist